• Strategic Technologies

Display 42 results

9 Mar 20
Regulatory, Finance Tax Investment, Overarching Political Issues, Strategic Technologies

BIA submission to Budget 2020

The UK is in a position to lead the world into a new age of technological advances, from gene-editing therapies that could permanently cure disease to genetically modified bacteria that could rid the world of plastic waste. The Government’s focus on R&D and the life sciences sector can deliver these public benefits and build a self-sustaining innovation-based economy by harnessing our competitive advantages with smart policy decisions in the upcoming Budget.

27 Jan 20
Regulatory, Finance Tax Investment, Pre Clinical And Clinical Research, Manufacturing, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Skills People And Talent, Access To Medicines

Influencing and shaping our sector | BIA update: October 2019 - January 2020

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2019 to January 2020.

19 Jan 20
Regulatory, Finance Tax Investment, Manufacturing, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Skills People And Talent

UK life sciences: Catalysing investment and growth

This updated interim report sets out how the UK life sciences sector is driving investment and growth and makes the case for increased cost-effective public investment in the sector.

15 Jan 20
Regulatory, Finance Tax Investment, Overarching Political Issues, IP And Technology Transfer, Strategic Technologies, Access To Medicines, Consultation Response

BIA response to DIT consultation on UK-Japan trade

The BIA has responded to the Department for International Trade (DIT)’s consultation on UK-Japan trade.

View more